Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Make a choice that matters
The best care starts with the best information
See frequently asked questions about the Medicare Access and CHIP Reauthorization Act (MACRA).
Members - keep an eye on your inbox for our MACRAlerts
Get a quick look at what's happening with MACRA
Learn about MACRA. Visit our MACRA FAQs, glossary page and this section to find the most up-to-date information on this important and developing topic. And watch your inbox for MACRAlerts. Each MACRAlert will provide vital MACRA news.
On April 16, 2015, President Obama signed into law the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). As the policies passed in this new legislation are rolled out over the coming years, comprehensive changes in how Medicare pays physicians for services will be introduced. Reimbursement for rheumatologists and their practices will change significantly. The law:
Under MACRA, nearly all physicians will have to choose between one of two paths: Merit-Based Incentive Payment System (MIPS), which consolidates existing Medicare fee-for-service physician incentive programs such as PQRS and meaningful use or participation in an Alternate Payment Model (APM)
“It is imperative that the rheumatology community understands the impending long-term effects of MACRA and engages in strategic thought about the best option for their practice. The ACR will be there, providing up-to-date information and support for its members. Information will be our most important tool in getting ahead of the curve and succeeding in this rapidly changing environment.” More >
- Joan M. Von Feldt, MD, MSEd, ACR Past President
The Quality Payment Program (QPP) has two tracks to choose from which allow you to participate based on your practice size, specialty, location, or patient population: MIPS and APMs.
Note: Details on MIPS will be the subject of policymaking for several years, but it is important to understand that some of the assessments made at the effective date of 2019 will be based upon 2017 data.
January 1, 2017: On this date the data from your practice began counting for Medicare reimbursement in 2019.
MACRA will transform how rheumatology practices/clinicians (1) conduct Medicare reporting requirements, and (2) are paid for the services provided to Medicare beneficiaries. The ultimate goal of these changes is to move toward a value-based healthcare system that ensures high-quality, affordable health care- quality over quantity.
To begin preparing its members for MACRA, ACR leadership from a number of highly engaged committees have joined forces to develop an action plan for the organization’s involvement in the implementation of the new law. This new ACR MACRA Working Group is developing an education, communication and advocacy strategy and is committed to helping our members navigate through the complexity of MACRA as it rolls out.
The ACR is committed to providing its members with resources and support to steer through the complication of MACRA.
Updated March 6, 2017